Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (341-350 of 607) with videos related to

Pageof 61
Sort By:
Proteomics. Clinical Applications|August 25, 2018
Proteomic Analysis of Human Scleroderma Fibroblasts Response to Transforming Growth Factor-ßBenjamin Chaigne, Guilhem Clary, Morgane Le Gall, et al.
The Lancet. Rheumatology|January 26, 2024
Digital ulcers: should debridement be a standard of care in systemic sclerosis?Michael Hughes, Begonya Alcacer-Pitarch, Yannick Allanore, et al.
The Journal of Rheumatology|October 2, 2020
STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung DiseaseDinesh Khanna, Donald P Tashkin, Athol U Wells, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 29, 2015
Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial HypertensionVincent Sobanski, Jonathan Giovannelli, Bernadette M Lynch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2018
Cardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanismSumia A Bageghni, Karen E Hemmings, Ngonidzashe Zava, et al.
Rheumatology (Oxford, England)|June 9, 2023
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung diseaseYannick Allanore, Dinesh Khanna, Vanessa Smith, et al.
Plos One|July 18, 2019
Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosisAurora Almadori, Michelle Griffin, Caroline M Ryan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2017
Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic SclerosisNicole S Goh, Rachel K Hoyles, Christopher P Denton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes With Disease in Patients With Systemic SclerosisTaher E Taher, Voon H Ong, Jonas Bystrom, et al.
Annals of the Rheumatic Diseases|July 2, 2014
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR databaseBritta Maurer, Nicole Graf, Beat A Michel, et al.
Pageof 61

Showing results (341-350 of 607) with videos related to

Sort By:
Pageof 61
Proteomics. Clinical Applications|August 25, 2018
Proteomic Analysis of Human Scleroderma Fibroblasts Response to Transforming Growth Factor-ßBenjamin Chaigne, Guilhem Clary, Morgane Le Gall, et al.
The Lancet. Rheumatology|January 26, 2024
Digital ulcers: should debridement be a standard of care in systemic sclerosis?Michael Hughes, Begonya Alcacer-Pitarch, Yannick Allanore, et al.
The Journal of Rheumatology|October 2, 2020
STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung DiseaseDinesh Khanna, Donald P Tashkin, Athol U Wells, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 29, 2015
Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial HypertensionVincent Sobanski, Jonathan Giovannelli, Bernadette M Lynch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2018
Cardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanismSumia A Bageghni, Karen E Hemmings, Ngonidzashe Zava, et al.
Rheumatology (Oxford, England)|June 9, 2023
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung diseaseYannick Allanore, Dinesh Khanna, Vanessa Smith, et al.
Plos One|July 18, 2019
Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosisAurora Almadori, Michelle Griffin, Caroline M Ryan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2017
Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic SclerosisNicole S Goh, Rachel K Hoyles, Christopher P Denton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes With Disease in Patients With Systemic SclerosisTaher E Taher, Voon H Ong, Jonas Bystrom, et al.
Annals of the Rheumatic Diseases|July 2, 2014
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR databaseBritta Maurer, Nicole Graf, Beat A Michel, et al.
Pageof 61